← All trials
NCT05175235
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Aug 1, 2023
- First posted
- Jan 3, 2022
- Last posted
- Jul 5, 2022
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National University of SingaporeLead sponsor
- University of NottinghamOverall official - principal investigator
- Natera, Inc.Collaborator
- The N.1 Institute for Health (N.1)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.